Effect of salmeterol/fluticasone combination on the dynamic changes of lung mechanics in mechanically ventilated COPD patients: a prospective pilot study

References

• MahlerDAWirePHorstmanDEffectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200216681084109112379552
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• CalverleyPPauwelsRVestboJCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet2003361935644945612583942
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• DaviesLAngusRMCalverleyPMOral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trialLancet1999354917745646010465169
   PubMed Web of Science ®Google Scholar
• NiewoehnerDEErblandMLDeupreeRHEffect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study GroupN Engl J Med1999340251941194710379017
   PubMed Web of Science ®Google Scholar
• NavaSCompagnoniMLControlled short-term trial of fluticasone propionate in ventilator-dependent patients with COPDChest2000118499099911035668
   PubMed Web of Science ®Google Scholar
• GuglielminottiJDesmontsJMDureuilBEffects of tracheal suctioning on respiratory resistances in mechanically ventilated patientsChest19981135133513389596316
   PubMed Web of Science ®Google Scholar
• RossiAGottfriedSBHiggsBDZocchiLGrassinoAMilic-EmiliJRespiratory mechanics in mechanically ventilated patients with respiratory failureJ Appl Physiol1985586184918584008405
   PubMed Web of Science ®Google Scholar
• BatesJHRossiAMilic-EmiliJAnalysis of the behavior of the respiratory system with constant inspiratory flowJ App Physiol198558618401848
   PubMed Web of Science ®Google Scholar
• DuarteAGMomiiKBidaniABronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of responseRespir Care200045781782310926377
   PubMedGoogle Scholar
• HollandASmithFPennyKMcCrossanGVeitchLNicholsonCMetered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care unitsCochrane Database Syst Rev20136CD00886323740736
   PubMed Web of Science ®Google Scholar
• MouloudiEKatsanoulasKAnastasakiMAskitopoulouEGeorgopoulosDBronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of end-inspiratory pauseEur Respir J19981211651699701432
   PubMed Web of Science ®Google Scholar
• MalliotakisPMouloudiEPrinianakisGKondiliEGeorgopoulosDInfluence of respiratory efforts on b2-agonist induced bronchodilation in mechanically ventilated COPD patients: a prospective clinical studyRespir Med2007101230030716774821
   PubMed Web of Science ®Google Scholar
• MalliotakisPLinardakisMGavriilidisGGeorgopoulosDDuration of salmeterol-induced bronchodilation in mechanically ventilated chronic obstructive pulmonary disease patients: a prospective clinical studyCrit Care2008126R14019014570
   PubMed Web of Science ®Google Scholar
• CazzolaMNoschesePDe MicheleFD’AmatoGMateraMGEffect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPDRespir Med2006100221221715936184
   PubMed Web of Science ®Google Scholar
• GrossNJBankwalaZEffects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Comparison with a beta-adrenergic agentAm Rev Respir Dis19871365109110943118746
   PubMed Web of Science ®Google Scholar
• KarpelJPPesinJGreenbergDGentryEA comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPDChest19909848358392145136
   PubMed Web of Science ®Google Scholar
• KhoukazGGrossNJEffects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Comparison with albuterol and ipratropiumAm J Respir Crit Care Med199916031028103010471636
   PubMed Web of Science ®Google Scholar
• SantusPCentanniSMorelliNDi MarcoFVergaMCazzolaMTiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta2-agonistsRespir Med200710181798180317399972
   PubMed Web of Science ®Google Scholar
• CazzolaMManteroASantusPDoppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patientsPulm Pharmacol Ther200720325826416600647
   PubMed Web of Science ®Google Scholar
• WagnerPDDantzkerDRIacovoniVETomlinWCWestJBVentilation-perfusion inequality in asymptomatic asthmaAm Rev Respir Dis19781183511524707879
   PubMed Web of Science ®Google Scholar
• HorvathGLiebTConnerGESalatheMWannerASteroid sensitivity of norepinephrine uptake by human bronchial arterial and rabbit aortic smooth muscle cellsAm J Respir Cell Mol Biol200125450050611694456
   PubMed Web of Science ®Google Scholar
• SalviSSAlpha1-adrenergic hypothesis for pulmonary hypertensionChest199911561708171910378571
   PubMed Web of Science ®Google Scholar
• LoselRWehlingMNongenomic actions of steroid hormonesNat Rev Mol Cell Biol200341465612511868
   PubMed Web of Science ®Google Scholar
• CatoACNestlAMinkSRapid actions of steroid receptors in cellular signaling pathwaysSci STKE20022002138re912084906
   PubMedGoogle Scholar
• SinDDManSFCorticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseasesEur J Pharmacol20065331–3283516457807
   PubMed Web of Science ®Google Scholar
• NanniniLJPoolePMilanSJHolmesRNormansellRCombined corticosteroid and long-acting beta(2)-agonist in one inhaler versus placebo for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201311CD00379424214176
   PubMed Web of Science ®Google Scholar
• FentonCKeatingGMInhaled salmeterol/fluticasone propionate: a review of its use in chronic obstructive pulmonary diseaseDrugs200464171975199615329047
   PubMed Web of Science ®Google Scholar
• HananiaNADarkenPHorstmanDThe efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPDChest2003124383484312970006
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J2003211748112570112
   PubMed Web of Science ®Google Scholar
• SinghDTutuncuALohrICarlholmMPolanowskiTBudesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalenceInt J Clin Pharmacol Ther200745948549517907591
   PubMed Web of Science ®Google Scholar
• KempsfordRHandelMMehtaRDe SilvaMDaley-YatesPComparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjectsRespir Med200599Suppl AS11S1915777604
   PubMed Web of Science ®Google Scholar
• ChopraNWilliamsMRimmerMKahlLJenkinsMSalmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthmaRespir Med200599Suppl AS1S1015777603
   PubMed Web of Science ®Google Scholar
• Grzelewska-RzymowskaIMalolepszyJde MolinaMSladekKZarkoviceJSiergiejkoZEquivalent asthma control and systemic safety of inhaled budesonide delivered via HFA-134a or CFC propellant in a broad range of dosesRespir Med200397Suppl DS10S1914753247
   PubMed Web of Science ®Google Scholar
• MichelettoCGuerrieroMTognellaSDal NegroRWEffects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthmaRespir Med200599785085515939246
   PubMed Web of Science ®Google Scholar
• LeachCLColiceGLA pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breath-hold timesJ Aerosol Med Pulm Drug Deliv201023635536120575669
   PubMed Web of Science ®Google Scholar